Replies to post #105145 on MultiCorp International Inc (MCIC)

[MLR_Lite]

Sam knew from the start that he would be issued restricted shares that he had to hold for 1 year, that is the law isn't it (rule 144)? So what would change his mind AFTER he signed the deal. He knew and agreed to the terms.

[JC8484]

Lee understood what was happening prior to signing the agreement.

The shares were always there and were converted from preferred into common shares that were restricted for one year. Again your arguement does not make sense - LEE had the most to gain by this deal working when he agreed to 541 million shares as his purchase price. Common sense would say LEE shouldn't have cared about the PPS he sold the device for because that was nothing in comparison to what his ultimate windfall would have been in the future when this company brought the device to market.

WOW 541X$1 = $541 million; crips, he would have been a frickin billionaire at $2 PPS. Lee's decision makes no sense to me, especially if the device actually can do as advertised, if it does not work than the scam concept makes no sense.


XTend Medical Corporation (XMDC) Discusses Corporate Structure

SUN VALLEY, CA -- (Marketwire)
11/19/09
XTend Medical (PINKSHEETS: XMDC), a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following statement regarding their corporate structure:

"We've had several email inquiries as to the company's corporate structure

regarding the press release issued on November 18th in regards to the upcoming asset purchase and merger with BioHarp.

Our current authorized share structure will not change in order to effectuate this transaction. Our current capital reserves are also sufficient to consummate the asset purchase. We have began the process of converting preferred shares into common shares in order to insure the integrity of the company as we move
forward to gain a listing on a higher exchange. There will be no need to alter our authorized shares whatsoever. In addition, the potential of the company in the future would justify us maintaining our current share structure with no plans to reverse the stock. Mr. Friedman and I feel strongly enough about the BioHarp that we will be utilizing our equity in the company to finalize any shares issued for the transaction.

As for any delays perceived, it is my responsibility as CEO of XTend to insure the company has taken the proper steps to insure our valuation is at the greatest and we adhere to all U.S. and international tax laws and regulations. The company will finalize any merger opportunities, now and in the future, in the proper manner so as to insure the future of the company is not placed in harms way," stated Mr. Paul D. Lisenby, CEO of XTend